2. Roy AK, Mc Gorrian C, Treacy C, et al. A Comparison of traditional and novel Definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med 2013; 3: 26–37.
3. Newhouse JH, Kho D, Rao QA, et al. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008; 191: 376–382.
4. Bruce RJ, Djamali A, Shinki K, et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 2009; 192: 711–718.
5. Sinert R, Brandler E, Subramanian RA, et al. Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? Acad Emerg Med 2012; 19: 1261–1267.
6. McDonald RJ, McDonald JS, Carter RE, et al. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 2014; 273: 714–725.
7. Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Critical care (London, England) 2012; 16: R67.
8. Hinson JS, Ehmann MR, Fine DM, et al. Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 2017; 69(5): 577–586.
9. Katzberg RW, Halley C. Contrast-induced nephrotoxicity: Clinical lansdscape. Kidney Int 2006; 69 (Suppl 100): S3–S7.
10. Brendan J, Barrett MB, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379–386.
11. Peer S, Choh NA, Gojwari TA. Incidence of contrast-induced nephropathy a prospective study. J Renal Inj Prev 2017; 6(3): 192–198.
12. McCullough PA. Contrast-induced acute kidney injury. JACC Vol. 51, No. 15, 2008.
13. Solomon R. Preventing contrast-induced nephropathy: problems, challenges and future directions. BMC Medicine 2009; 7: 24.
14. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. NEPHRIC Study. N Engl J Med 2003; 348: 491–499.
15. Jo SH, Youn TJ, Koo BK, et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol. 2006; 5; 48(5): 924–30.
16. Botev R, Mallié JP, Wetzels JFM, et al. The clinician and estimation of glomerular filtration rate by creatinine-based formulas: Current limitations and quo vadis. CJASN 2011; 6(4): 937–950.
17. Liu Y, Tan N, Zhou YL, et al. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 2012; 44: 221–229.
18. Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: A primer for the non-radiologist. Mayo Clin Proc. 2012; 87(4): 390–402.
19. Jurado-Roman A, Hernandez-Hernandez F, Garcia-Tejada J, et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol 2015; 115(9): 1174–1178.
20. Chalikias G, Drosos I, Tziakas DN. Prevention of contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther 2016; 30: 515–524.
21. Mueller C, Buerkle G, Buettner H, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329–336.
22. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical practice guideline for acute kidney injury. Kidney inter, Suppl. 2012; 2(1): 1–138.
23. Zhang B, Liang L, Chen W, et al. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis. BMJ Open 2015; 5(3): e006989.
24. Jang JS, Jin HY, Seo JS, et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury - A systematic review and meta-analysis. Circ J. 2012; 76(9): 2255–2265.
25. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004 May 19; 291(19):2 328–34.
26. Trivedi H, Nadella R, Szabo A. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Clin Nephrol 2010; 74: 288–296.
27. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008; 52: 599–604.
28. Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 2017; 389(10076): 1312–1322.
29. McCullough PA, Zhang J, Ronco C. Volume expansion and contrast-induced acute kidney injury. Lancet 2017; 389: 1277–1278.
30. Raje V, Feldman G, Jovin IS. Diagnosing and treating contrast-induced acute kidney injury in 2017. J Thorac Dis 2017; 9(6): 1443–1445.
31. Dorval JF, Dixon SR, Zelman RB, et al. Feasibility study of the RenalGuard balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients. Int J Cardiol 2013; 166(2): 482–486.
32. Gu G, Zhang Y, Lu R, et al. Additional furosemide treatment beyond saline hydration for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Int J Clin Exp Med 2015; 8(1): 387–394.
33. Duan N, Zhao J, Li Z, et al. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: A meta-analysis of randomized controlled trials. Med Sci Monit 2015; 21: 292–297.
34. Yang B, Xu J, Xu F, et al. Intravascular administration of mannitol for acute kidney injury prevention: A systematic review and meta-analysis. PLoS One 2014; 9(1): e85029.
35. Sang-Ho Jo. N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review. Korean Circ J 2011; 41(12): 695–702.
36. Dai B, Liu Y, Fu L, et al. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012; 60(3): 360–370.
37. Marenzi G, Cosentino N, Werba JP, et al. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol 2015; 183: 47–53.
38. Briasoulis A, Mallikethi-Reddy S, Sharma S, et al. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies. Am J Ther. 2015; 22(6): 158–166.
39. Liu YH, Liu Y, Duan CY, et al. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther 2015; 20(2): 181–192.
40. Giacoppo D, Capodanno D, Capranzano P, et al. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. Am J Cardiol 2014; 114(4): 541–548.
41. Kawashima S, Takano H, Iino Y, et al. Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J 2006; 70(5): 553-558.
42. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692–698.
43. Ghani AA, Hussain N, Al Helal B. Can continuous venovenous hemofiltration prevent contrast-agent induced nephropathy in patients with advanced chronic kidney disease after coronary angiography? Saudi J Kidney Dis Transpl 2011; 22(1): 54–60.
44. Choi MJ, Yoon JW, Han SJ, et al. The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration. 2014; 176(3): 941–945.